Clarivate Plc - CLVT STOCK NEWS

Clarivate Plc (NYSE:CLVT) has launched the COVID-19 Vaccine Availability and Medtech Impact Report, forecasting vaccination rates across countries in 2021. The report indicates that vaccine acceptance varies by region, with rates of 94% in Malaysia and 71% in the U.S. It highlights the importance of vaccination in recovering healthcare markets post-pandemic, particularly for Ambulatory Surgery Centers (ASCs) which showed higher utilization rates. The predictive analysis leverages real-world data to aid healthcare stakeholders in planning and decision-making.

Clarivate Plc (NYSE: CLVT) has announced a commercial partnership with Explore IP to integrate Derwent™ patent data into its platform. This collaboration aims to enhance the searchability of intellectual property data, enabling businesses and innovators to identify and understand patents held by Canadian public sector institutions. The partnership will facilitate licensing opportunities and foster innovation by providing access to authoritative patent information. This integration will support Canadian entrepreneurs and significantly improve the marketability of public sector technologies.

On May 26, 2021, Clarivate Plc (NYSE: CLVT) announced that its Executive Chairman and CEO, Jerre Stead, along with CFO Richard Hanks, will present at three upcoming virtual investor conferences in June 2021. The conferences include: William Blair's 41st Annual Growth Stock Conference on June 2 at 10:00 am CT, Baird's 2021 Global Consumer, Technology & Services Conference on June 8 at 12:15 pm ET, and Stifel's 2021 Virtual Cross Sector Insight Conference on June 10 at 8:00 am ET. Live webcasts will be available for each event.

On May 18, 2021, Clarivate Plc (NYSE:CLVT) announced a strategic partnership with Alt Legal, Inc. to integrate CompuMark™ international trademark data into Alt Legal's platform. This collaboration aims to enhance Alt Legal's offerings by providing access to 186 trademark databases globally. The integration will allow users to receive updates on trademark filings, streamline workflows, and minimize human error. Alt Legal is responding to client demand for broader international capabilities, positioning itself as a leading docketing solution for global trademark management.

Clarivate (NYSE: CLVT) has agreed to acquire ProQuest for $5.3 billion, enhancing its position as a leading provider of research intelligence solutions. The deal includes $4 billion in cash and $1.3 billion in equity, with expected closing in Q3 2021. ProQuest serves over 25,000 institutions globally, and this acquisition will expand Clarivate’s data offerings significantly. Financially, the transaction is projected to be accretive to earnings, with anticipated cost synergies exceeding $100 million within 15-18 months, paired with substantial cash tax savings.

Clarivate Plc (NYSE: CLVT) will present at the Barclays Americas Select Franchise Conference on May 19, 2021, at 1:00 PM Eastern Time. The presentation will feature Executive Chairman and CEO Jerre Stead and CFO Richard Hanks. A live webcast will be available on the Investor Relations section of Clarivate's website, with a replay accessible for 30 days post-event. Clarivate is dedicated to accelerating innovation through actionable insights and solutions in science and intellectual property.

Clarivate reaffirmed its 2021 outlook for key financial metrics including Adjusted revenues, Adjusted EBITDA, and Adjusted free cash flow. The company also filed its Form 10-Q for Q1 2021, reporting a net loss of $24.0 million ($0.04 per diluted share), an improvement from a loss of $129.6 million in Q1 2020. Adjusted net income rose to $88.4 million ($0.14 per diluted share) versus $25.5 million ($0.07 per diluted share) year-over-year. Additionally, adjustments were made to the classification of certain warrants as liabilities, impacting financial statements without altering reported revenues or cash flows.

Clarivate Plc (NYSE: CLVT) announced the winners of the 2020 Revenue Cycle Awards, recognizing healthcare organizations for outstanding performance in revenue cycle KPIs. The winners include ThedaCare (WI), University of Iowa Hospitals & Clinics (IA), and Essentia Health (MN). Award recipients adapted to pandemic challenges, enhancing operations to support staff and patients. Winners demonstrated top decile performance metrics, including first-pass appeal success rates and online payment percentages, showcasing effective revenue cycle management amidst the COVID-19 crisis.